Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Temporal triangular alopecia is a lifelong condition with hairless patches on the side of the head that may be present from birth.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

New drug shows promise for better hair growth in baldness treatment.

A substance called TCQA could potentially darken hair by activating certain genes and increasing melanin.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Dupilumab helped a 13-year-old regrow hair after alopecia totalis.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Terminalia chebula fruit extract helps hair growth by reducing DHT and boosting hair cell activity.

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

Letrozole reduces seizures but not brain damage in mice.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

An 80-year-old man grew extra hair on his forearms after starting Alzheimer's medication rivastigmine.